Knopp Biosciences Explore Our Pipeline

Developing Breakthrough Medications for Immunological and Neurological Conditions

Scroll to discover
Explore Our Pipeline

Dexpramipexole

Slide the table to the Left

Immunology
Dicovery
Preclinical
Phase 1
Phase 2
Phase 3
Compound
Indication
Dexpramipexole
Moderate-to-severe eosinophilic asthma
Dexpramipexole
Hypereosinophilic syndrome

Neurology (Kv7 Platform)

Slide the table to the Left

Immunology
Dicovery
Preclinical
Phase 1
Phase 2
Phase 3
Compound
Indication
KB-3061
KCNQ2 epileptic encephalopathy
Kv7 modulator
Neuropathic pain
Kv7 modulator
Hearing disorders
Kv7 modulator
ALS

Revolutionizing Medicine, One Medication at a Time

Dexpramipexole

A Novel Oral Approach in Development for Moderate-to-Severe Asthma

Explore Dexpramipexole

Kv7

Knopp’s Potential Solution to Epileptic Encephalopathy

Explore Kv7